Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
作者信息
Warner Timothy D, Mitchell Jane A
机构信息
The William Harvey Research Institute, Bart's and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United Kingdom.
出版信息
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3. doi: 10.1073/pnas.222543099. Epub 2002 Oct 8.
Abstract
摘要
相似文献
1
Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?环氧化酶-3（COX-3）：向COX连续体填补空白？
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3. doi: 10.1073/pnas.222543099. Epub 2002 Oct 8.
2
The discovery and function of COX-2.环氧化酶-2（COX-2）的发现及其功能
J Rheumatol Suppl. 1997 Jul;49:6-8.
3
COX-2 inhibitors--is there cause for concern?环氧化酶-2抑制剂——是否值得担忧？
Nat Med. 1999 Jun;5(6):621-2. doi: 10.1038/9465.
4
Cox-2-selective inhibitors: the new super aspirins.环氧化酶-2选择性抑制剂：新型超级阿司匹林
Mol Pharmacol. 1999 Apr;55(4):625-31.
5
[New NSAIDS: COX-1, COX-2, what about them?].[新型非甾体抗炎药：COX - 1、COX - 2，它们是怎么回事？]
Rev Med Brux. 1998 Sep;19(4):A399-402.
6
COX-1 and COX-2 inhibition: current status and future perspective.环氧化酶-1与环氧化酶-2抑制作用：现状与未来展望
Acta Anaesthesiol Belg. 1998;49(3):175-83.
7
The future of NSAID therapy: selective COX-2 inhibitors.非甾体抗炎药治疗的未来：选择性环氧化酶-2抑制剂
Int J Clin Pract. 2000 Jan-Feb;54(1):7-9.
8
[COX-1 and COX-2: functions and pharmacological effects].[环氧化酶-1与环氧化酶-2：功能及药理作用]
Pharm Unserer Zeit. 1999 Jan;28(1):21-9.
9
[In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].[非甾体抗炎药对大鼠COX - 1 - COX - 2的体内选择性及胃肠道溃疡]
Acta Gastroenterol Latinoam. 1998;28(3):249-55.
10
[Biological functions of cyclooxygenase 2: control of its expression and activity].[环氧化酶2的生物学功能：其表达与活性的调控]
J Soc Biol. 2000;194(3-4):189-93.
引用本文的文献
1
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.非甾体抗炎药包裹的纳米颗粒作为调节慢性炎症和抑制癌症进展的靶向治疗平台：综述
Inflammopharmacology. 2025 Apr 26. doi: 10.1007/s10787-025-01760-8.
2
Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT).长期低剂量阿司匹林在幽门螺杆菌根除后预防胃癌的效果：阿瓦士胃癌随机安慰剂对照预防试验（AGCPT）的研究设计和原理。
Trials. 2024 Sep 19;25(1):617. doi: 10.1186/s13063-024-08455-5.
3
A Narrative Review of the Published Pre-Clinical Evaluations: Multiple Effects of Arachidonic Acid, its Metabolic Enzymes and Metabolites in Epilepsy.已发表的临床前评估的叙述性综述：花生四烯酸及其代谢酶和代谢产物在癫痫中的多种作用
Mol Neurobiol. 2025 Jan;62(1):288-303. doi: 10.1007/s12035-024-04274-6. Epub 2024 Jun 6.
4
Analgesic Efficacy of Non-Steroidal Anti-Inflammatory Drug Therapy in Horses with Abdominal Pain: A Systematic Review.非甾体抗炎药治疗腹痛马匹的镇痛效果：一项系统评价
Animals (Basel). 2023 Nov 8;13(22):3447. doi: 10.3390/ani13223447.
5
A Spontaneous Spinal Epidural Hematoma Secondary to Long-Term Low-Dose Aspirin and Clopidogrel Use: A Case Report.长期低剂量使用阿司匹林和氯吡格雷继发自发性脊髓硬膜外血肿：1例报告
Cureus. 2023 Feb 2;15(2):e34537. doi: 10.7759/cureus.34537. eCollection 2023 Feb.
6
Rhenium(V) Complexes as Cysteine-Targeting Coordinate Covalent Warheads.铼（V）配合物作为半胱氨酸靶向的配位共价弹头。
J Med Chem. 2023 Feb 23;66(4):3088-3105. doi: 10.1021/acs.jmedchem.2c02074. Epub 2023 Feb 8.
7
Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects.非甾体抗炎药在癌症治疗中的应用前景：克服其不良副作用的尝试
Cancers (Basel). 2023 Jan 12;15(2):475. doi: 10.3390/cancers15020475.
8
Acetylsalicylic Acid-Primus Inter Pares in Pharmacology.乙酰水杨酸——药理学中的首屈一指。
Molecules. 2022 Dec 1;27(23):8412. doi: 10.3390/molecules27238412.
9
Applications of covalent chemistry in targeted protein degradation.共价化学在靶向蛋白降解中的应用。
Chem Soc Rev. 2022 Nov 14;51(22):9243-9261. doi: 10.1039/d2cs00362g.
10
Cyclooxygenase-2 immunohistochemical expression is associated with worse prognosis in breast cancer: Retrospective study and literature review.环氧化酶-2 的免疫组织化学表达与乳腺癌的预后不良相关：回顾性研究和文献复习。
Saudi Med J. 2022 Jul;43(7):687-693. doi: 10.15537/smj.2022.43.7.20220052.
本文引用的文献
1
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.COX-3，一种受对乙酰氨基酚和其他止痛/退烧药抑制的环氧化酶-1变体：克隆、结构与表达
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. doi: 10.1073/pnas.162468699. Epub 2002 Sep 19.
2
Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.外周前列腺素水平与非甾体抗炎药镇痛作用：组织损伤模型中的重复临床试验
Clin Pharmacol Ther. 2002 Aug;72(2):175-83. doi: 10.1067/mcp.2002.126501.
3
Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.罗非昔布与肠溶双氯芬酸钠治疗术后牙痛的镇痛疗效比较：一项随机、安慰剂对照临床试验
Clin Ther. 2002 Apr;24(4):490-503. doi: 10.1016/s0149-2918(02)85126-8.
4
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.对乙酰氨基酚作为前列腺素H(2)合成酶抑制剂的细胞特异性的决定因素。
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7130-5. doi: 10.1073/pnas.102588199.
5
Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.大鼠中COX-1抑制导致COX-2上调：非甾体抗炎药诱导胃损伤的关键。
Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:90-101. doi: 10.1046/j.1365-2036.16.s2.22.x.
6
Pharmacology of cyclooxygenase-2 inhibition in the kidney.肾脏中环氧合酶-2抑制的药理学
Kidney Int. 2002 Apr;61(4):1210-9. doi: 10.1046/j.1523-1755.2002.00263.x.
7
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.非选择性非甾体抗炎药与环氧化酶-2选择性抑制剂的心血管药理学：临床考量
Am J Cardiol. 2002 Mar 21;89(6A):26D-32D. doi: 10.1016/s0002-9149(02)02234-8.
8
Cyclooxygenase-2: a therapeutic target.环氧化酶-2：一个治疗靶点。
Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952.
9
The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing.伤害性感受处理中的脊髓磷脂酶-环氧化酶-前列腺素级联反应。
Annu Rev Pharmacol Toxicol. 2002;42:553-83. doi: 10.1146/annurev.pharmtox.42.092401.143905.
10
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.伐地考昔，一种环氧化酶-2特异性抑制剂，在接受髋关节置换术的患者中是一种有效的、可减少阿片类药物用量的镇痛药。
Am J Ther. 2002 Jan-Feb;9(1):43-51. doi: 10.1097/00045391-200201000-00009.
Zotero 插件